日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Redefining skin toxicity in the age of precision immunotherapy

重新定义精准免疫疗法时代的皮肤毒性

Dimitriou, Florentia; Posch, Christian

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy

将PD-1抑制剂替换为BRAF+MEK抑制剂可提高接受第二疗程辅助黑色素瘤治疗患者的无复发生存期。

Schumann, Katharina; Klespe, Kai Christian; Mauch, Cornelia; Loquai, Carmen; Schultheis, Ulrike; Börger, Sevil; Thiem, Alexander; Emmert, Steffen; Hoellwerth, Magdalena; Kölblinger, Peter; Nguyen, Van Anh; Wanner, Marina; Richtig, Erika; Peitsch, Wiebke K; Harth, Wolfgang; Zenderowski, Veronika; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Johanna; Maul, Lara Valeska; Meiß, Frank; Rappersberger, Klemens; Persa, Oana Diana; Biedermann, Tilo; Posch, Christian

Non-invasive characterization of melanoma depth at single-cell resolution

以单细胞分辨率对黑色素瘤深度进行非侵入性表征

Aguirre, Juan; Gasteiger, Christine; Hindelang, Benedikt; Seeger, Markus; Bereznhoi, Andrei; Weidenfeld, Ina; Darsow, Ulf; Stiel, Andre C; Steimle-Grauer, Susanne Annette; Posch, Christian; Biedermann, Tilo; Ntziachristos, Vasilis

The Hidden Socioeconomic Toll of Severe Hidradenitis Suppurativa

严重化脓性汗腺炎的隐性社会经济损失

Regensberger, Florian; André, Fiona; Maier, Sarah; Posch, Christian; Schmuth, Matthias

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors

微生物代谢产物脱氨基酪氨酸可增强T细胞启动和免疫检查点抑制剂的癌症免疫疗法。

Joachim, Laura; Göttert, Sascha; Sax, Anna; Steiger, Katja; Neuhaus, Klaus; Heinrich, Paul; Fan, Kaiji; Orberg, Erik Thiele; Kleigrewe, Karin; Ruland, Jürgen; Bassermann, Florian; Herr, Wolfgang; Posch, Christian; Heidegger, Simon; Poeck, Hendrik

Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting Identity.

炎症信号引导皮肤驻留的 1 型固有淋巴细胞获得促进银屑病的特性

Evers Beatrix D G, Hils Miriam, Heuser Christoph, Hölge Inga M, Argiriu Désirée, Skabytska Yuliya, Kaesler Susanne, Posch Christian, Knolle Percy A, Biedermann Tilo

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

伊匹木单抗联合纳武利尤单抗治疗阿维鲁单抗难治性默克尔细胞癌:一项来自前瞻性皮肤癌登记处ADOREG的多中心研究

Glutsch, Valerie; Schummer, Patrick; Kneitz, Hermann; Gesierich, Anja; Goebeler, Matthias; Klein, Detlef; Posch, Christian; Gebhardt, Christoffer; Haferkamp, Sebastian; Zimmer, Lisa; Becker, Jürgen C; Leiter, Ulrike; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

COVID-19 对接受免疫检查点抑制剂治疗的癌症患者的临床影响

Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Joanna; Pimentel Muniz, Thiago; Cooksley, Tim; Lupu, Jeremy; Vaisman, Alon; Saibil, Samuel D; Butler, Marcus O; Menzies, Alexander M; Carlino, Matteo S; Erdmann, Michael; Berking, Carola; Zimmer, Lisa; Schadendorf, Dirk; Pala, Laura; Queirolo, Paola; Posch, Christian; Hauschild, Axel; Dummer, Reinhard; Haanen, John; Blank, Christian U; Robert, Caroline; Sullivan, Ryan J; Ascierto, Paolo Antonio; Miller, Wilson H Jr; Stephen Hodi, F; Suijkerbuijk, Karijn P M; Reynolds, Kerry L; Rahma, Osama E; Lorigan, Paul C; Carvajal, Richard D; Lo, Serigne; Mandala, Mario; Long, Georgina V

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

在奥地利、瑞士和德国的医疗中心,talimogene laherparepvec (T-VEC) 在黑色素瘤患者中的实际应用

Ressler, Julia Maria; Karasek, Matthias; Koch, Lukas; Silmbrod, Rita; Mangana, Joanna; Latifyan, Sofiya; Aedo-Lopez, Veronica; Kehrer, Helmut; Weihsengruber, Felix; Koelblinger, Peter; Posch, Christian; Kofler, Julian; Michielin, Olivier; Richtig, Erika; Hafner, Christine; Hoeller, Christoph

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

CTLA4启动子甲基化可预测接受抗CTLA-4免疫疗法(伊匹木单抗)治疗的IV期黑色素瘤患者的疗效和无进展生存期

Fietz, Simon; Zarbl, Romina; Niebel, Dennis; Posch, Christian; Brossart, Peter; Gielen, Gerrit H; Strieth, Sebastian; Pietsch, Torsten; Kristiansen, Glen; Bootz, Friedrich; Landsberg, Jennifer; Dietrich, Dimo